PUBLIC CONTRACT · 2022
509_2022 Ranibizumab 10 mg/ml Sol inj Fr 0.23 ml Intravítreo
- Contract value
- €5,323.80
- Signed on
- 14 October 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9503485PUBLISHED SUBJECT
509_2022 Ranibizumab 10 mg/ml Sol inj Fr 0.23 ml Intravítreo
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- NOVARTIS FARMA-PRODUTOS FARMACÊUTICOS, S.A. · Tax ID 500063524
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €5,323.80
- Procedure base price
- €5,323.80
- Total effective price
- €5,323.80
- Publication date
- 18 October 2022
- Award date
- 14 October 2022
- Signing date
- 14 October 2022
- Performance period
- 75 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2021/49 - Medicamentos usados nas afeções oculares e otorrinolaringológicas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6103392
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.